Inventor · disambiguated record
Sylvaine Cren
Also filed as: CREN SYLVAINE
15 granted patents·3 pending applications·30 citations·filing 2008–2020
89Inventor score
Top patents by PatentIndex Score
18 records- 0183US9850256B2Antibacterial basic biaromatic derivatives with aminoalkoxy substitutionIDORSIA PHARMACEUTICALS LTD·Filed 2015·Granted Dec 26, 2017·4 cites·15 claims
- 0281US8288419B2Aminopyrazole derivativesBUR DANIEL·Filed 2008·Granted Oct 16, 2012·7 cites·17 claims
- 0378US8846733B2Oxazolyl-methylether derivatives as ALX receptor agonistsBUR DANIEL·Filed 2011·Granted Sep 30, 2014·4 cites·17 claims
- 0476US8563714B2Bridged spiro [2.4] heptane derivatives as ALX receptor and/or FPRL2 agonistsBUR DANIEL·Filed 2010·Granted Oct 22, 2013·4 cites·34 claims
- 0574US11267824B2Inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan 2,3-dioxygenaseIDORSIA PHARMACEUTICALS LTD·Filed 2018·Granted Mar 8, 2022·1 cites·14 claims
- 0674US9284288B21-(p-tolyl) cyclopropyl substituted bridged spiro[2.4]heptane derivatives as ALX receptor agonistsACTELION PHARMACEUTICALS LTD·Filed 2013·Granted Mar 15, 2016·2 cites·16 claims
- 0774US8536209B2Aminotriazole derivatives as ALX agonistsBUR DANIEL·Filed 2008·Granted Sep 17, 2013·2 cites·22 claims
- 0867US9346793B2Hydroxylated aminotriazole derivatives as ALX receptor agonistsBUR DANIEL·Filed 2011·Granted May 24, 2016·1 cites·13 claims
- 0967US8580831B2Fluorinated aminotriazole derivativesBUR DANIEL·Filed 2010·Granted Nov 12, 2013·1 cites·22 claims
- 1066US9663473B2Benzimidazolyl-methyl urea derivatives as ALX receptor agonistsACTELION PHARMACEUTICALS LTD·Filed 2014·Granted May 30, 2017·1 cites·14 claims
- 1166US9527867B2Antibacterial biaromatic derivativesACTELION PHARMACEUTICALS LTD·Filed 2014·Granted Dec 27, 2016·1 cites·18 claims
- 1266US9187435B2Bridged Spiro[2.4]heptane ester derivativesBUR DANIEL·Filed 2011·Granted Nov 17, 2015·1 cites·14 claims
- 1366US8674111B2Oxazole and thiazole derivatives as ALX receptor agonistsBUR DANIEL·Filed 2010·Granted Mar 18, 2014·1 cites·13 claims
- 1453US9676761B2Difluoroethyl-oxazole substituted bridged spiro[2.4]heptane derivatives as ALX receptor agonistsACTELION PHARMACEUTICALS LTD·Filed 2014·Granted Jun 13, 2017·0 cites·7 claims
- 1553US9533964B2Piperazine substituted bridged spiro[2.4]heptane derivatives as ALX receptor agonistsACTELION PHARMACEUTICALS LTD·Filed 2014·Granted Jan 3, 2017·0 cites·5 claims
- 1644US2022259212A1Inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan 2,3-dioxygenaseIDORSIA PHARMACEUTICALS LTD·Filed 2020·Application pending·0 cites
- 1738US2020405696A1Inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan 2,3-dioxygenaseIDORSIA PHARMACEUTICALS LTD·Filed 2019·Application pending·0 cites
- 1837US2020325154A1Antibacterial biaromatic derivatives with oxetane-3-yloxy substitutionIDORSIA PHARMACEUTICALS LTD·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →